BIO-Europe Spring 2019: InteRNA Sees MicroRNA Potential In Cancer Therapy

 
• By Mike Ward

Roel Schaapveld is CEO of Dutch microRNA specialist InteRNA Technologies. He spoke to Mike Ward about the company’s therapeutic approach.

Video interview
Roel Schaapveld Describe's InteRNA's work in miRNA

More from R&D

More from Scrip